Bulk whole genome sequencing (WGS) enables the analysis of tumor evolution but, because of depth limitations, can only identify old mutational events. The discovery of current mutational processes for predicting the tumor's evolutionary trajectory requires dense sequencing of individual clones or single cells. Such studies, however, are inherently problematic because of the discovery of excessive false positive (FP) mutations when sequencing picogram quantities of DNA. Data pooling to increase the confidence in the discovered mutations, moves the discovery back in the past to a common ancestor. Here we report a robust WGS and analysis pipeline (DigiPico/MutLX) that virtually eliminates all F results while retaining an excellent proportion o...
© 2017, Springer Science+Business Media, LLC, part of Springer Nature. One cause of cancer mortality...
The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) curated consensus s...
The type and genomic context of cancer mutations depend on their causes. These causes have been char...
Bulk whole genome sequencing (WGS) enables the analysis of tumor evolution but, because of depth lim...
High-grade serous ovarian cancer (HGSOC) is amongst the deadliest of cancers. Despite decades of res...
Mutational processes acting on cancer genomes can be traced by investigating mutational signatures. ...
The nature and pace of genome mutation is largely unknown. Because standard methods sequence DNA fro...
As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding ...
Experimental models that recapitulate mutational landscapes of human cancers are needed to decipher ...
Although all cells in a human body are descendant from a single cell –i.e. the zygote– the genetic c...
As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding ...
Tumours accumulate many somatic mutations in their lifetime. Some of these mutations, drivers, conve...
Accelerating technological advances have allowed the widespread genomic profiling of tumors. As yet,...
Methods for reconstructing tumor evolution are benchmarked in the DREAM Somatic Mutation Calling Tum...
The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) curated consensus s...
© 2017, Springer Science+Business Media, LLC, part of Springer Nature. One cause of cancer mortality...
The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) curated consensus s...
The type and genomic context of cancer mutations depend on their causes. These causes have been char...
Bulk whole genome sequencing (WGS) enables the analysis of tumor evolution but, because of depth lim...
High-grade serous ovarian cancer (HGSOC) is amongst the deadliest of cancers. Despite decades of res...
Mutational processes acting on cancer genomes can be traced by investigating mutational signatures. ...
The nature and pace of genome mutation is largely unknown. Because standard methods sequence DNA fro...
As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding ...
Experimental models that recapitulate mutational landscapes of human cancers are needed to decipher ...
Although all cells in a human body are descendant from a single cell –i.e. the zygote– the genetic c...
As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding ...
Tumours accumulate many somatic mutations in their lifetime. Some of these mutations, drivers, conve...
Accelerating technological advances have allowed the widespread genomic profiling of tumors. As yet,...
Methods for reconstructing tumor evolution are benchmarked in the DREAM Somatic Mutation Calling Tum...
The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) curated consensus s...
© 2017, Springer Science+Business Media, LLC, part of Springer Nature. One cause of cancer mortality...
The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) curated consensus s...
The type and genomic context of cancer mutations depend on their causes. These causes have been char...